Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Gilenya on Cognitive Function and Thalamic Volume Measured by 7 Tesla MRI in Multiple Sclerosis

NCT03243721 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03243721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03243721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Gilenya on Cognitive Function and Thalamic Volume Measured by 7 Tesla MRI in Multiple Sclerosis
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 20, 2017
Completion date
November 12, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis